Q7Z5J4 (RAI1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 87.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Retinoic acid-induced protein 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1906 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May function as a transcriptional regulator. Regulates transcription through chromatin remodeling by interacting with other proteins in chromatin as well as proteins in the basic transcriptional machinery. May be important for embryonic and postnatal development. May be involved in neuronal differentiation By similarity. |
| Subcellular location | Cytoplasm. Nucleus. Note: In neurons, localized to neurites By similarity. |
| Tissue specificity | Expressed in all tissues examined with higher expression in the heart and brain. No expression was seen in the corpus callosum of the brain. Ref.2 |
| Polymorphism | The poly-Gln tract is polymorphic and the number of Gln varies from 12 to 14. The size of the poly-Gln region may influence the age at onset of spinocerebellar ataxia type 2 (SCA2). |
| Involvement in disease | Smith-Magenis syndrome (SMS) [MIM:182290]: Characterized by congenital mental retardation associated with development and growth delays. Affected persons have characteristic behavioral abnormalities, including self-injurious behaviors and sleep disturbance, and distinct craniofacial and skeletal anomalies. |
| Sequence similarities | Contains 1 PHD-type zinc finger. |
| Sequence caution | The sequence BAB47449.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism Triplet repeat expansion |
| Domain | Zinc-finger |
| Ligand | Metal-binding Zinc |
| PTM | Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | negative regulation of multicellular organism growth Inferred from electronic annotation. Source: Compara regulation of transcription from RNA polymerase II promoterInferred from electronic annotation. Source: Compara skeletal system developmentInferred from electronic annotation. Source: Compara |
| Cellular_component | cytoplasm Inferred from electronic annotation. Source: UniProtKB-SubCell nucleusInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular_function | zinc ion binding Inferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q7Z5J4-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q7Z5J4-2) The sequence of this isoform differs from the canonical sequence as follows: 207-233: THFPQHSQSFPTSSTYSSSVQGGGQGA → WWAGG 407-434: VDTQAGNCKPLQKDKLPENLLSDLSLQS → PAD 1415-1479: Missing. 1803-1821: Missing. 1856-1906: MCSSCQEAGA...LKCPKHKRLP → HGGTVALAPG...LCWAMPGTWK | ||||||
| Isoform 3 (identifier: Q7Z5J4-3) The sequence of this isoform differs from the canonical sequence as follows: 1598-1640: FVRVEKRDAF...ASSSSSSSSF → LEPSLGAQNP...AYSAREQGQR 1641-1906: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 4 (identifier: Q7Z5J4-4) The sequence of this isoform differs from the canonical sequence as follows: 947-966: SHMKPGEEGPDGERAPGDST → YSVYICIHIHIYNIYEDCKC 967-1906: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1906 | 1906 | Retinoic acid-induced protein 1 | PRO_0000097159 | |||||
Regions | |||||||||
| Zinc finger | 1856 – 1903 | 48 | PHD-type | ||||||
| Motif | 1160 – 1177 | 18 | Nuclear localization signal Potential | ||||||
| Motif | 1223 – 1240 | 18 | Nuclear localization signal Potential | ||||||
| Compositional bias | 124 – 135 | 12 | Poly-Pro | ||||||
| Compositional bias | 156 – 336 | 181 | Gln-rich | ||||||
| Compositional bias | 278 – 291 | 14 | Poly-Gln | ||||||
| Compositional bias | 1243 – 1249 | 7 | Poly-Ser | ||||||
| Compositional bias | 1493 – 1496 | 4 | Poly-Gly | ||||||
| Compositional bias | 1628 – 1641 | 14 | Ser-rich | ||||||
| Compositional bias | 1746 – 1751 | 6 | Poly-Ala | ||||||
Amino acid modifications | |||||||||
| Modified residue | 568 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 683 | 1 | Phosphoserine Ref.9 Ref.10 Ref.11 | ||||||
| Modified residue | 696 | 1 | Phosphothreonine Ref.9 | ||||||
| Modified residue | 880 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 892 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 1064 | 1 | Phosphoserine Ref.10 | ||||||
| Modified residue | 1068 | 1 | Phosphothreonine Ref.10 | ||||||
| Modified residue | 1122 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 1352 | 1 | Phosphoserine Ref.9 Ref.11 | ||||||
| Modified residue | 1358 | 1 | Phosphoserine Ref.9 Ref.11 | ||||||
| Modified residue | 1374 | 1 | Phosphoserine Ref.9 Ref.10 Ref.11 | ||||||
| Modified residue | 1431 | 1 | Phosphoserine Ref.9 | ||||||
Natural variations | |||||||||
| Alternative sequence | 207 – 233 | 27 | THFPQ…GGQGA → WWAGG in isoform 2. | VSP_010995 | |||||
| Alternative sequence | 407 – 434 | 28 | VDTQA…LSLQS → PAD in isoform 2. | VSP_010996 | |||||
| Alternative sequence | 947 – 966 | 20 | SHMKP…PGDST → YSVYICIHIHIYNIYEDCKC in isoform 4. | VSP_010997 | |||||
| Alternative sequence | 967 – 1906 | 940 | Missing in isoform 4. | VSP_010998 | |||||
| Alternative sequence | 1415 – 1479 | 65 | Missing in isoform 2. | VSP_010999 | |||||
| Alternative sequence | 1598 – 1640 | 43 | FVRVE…SSSSF → LEPSLGAQNPRSGQNAPPAP ADARPLCTTRDRRAYSAREQ GQR in isoform 3. | VSP_011000 | |||||
| Alternative sequence | 1641 – 1906 | 266 | Missing in isoform 3. | VSP_011001 | |||||
| Alternative sequence | 1803 – 1821 | 19 | Missing in isoform 2. | VSP_011002 | |||||
| Alternative sequence | 1856 – 1906 | 51 | MCSSC…HKRLP → HGGTVALAPGDFSLPGLRFA SLFQGPSWCDCPVLATSTPS SWSRCVPAAKKPGPPLGAAT KDASTPTTTRVPAMQVRARP GTGGHWSPSKQSRGTLPGHS SPNPGPISLFSFPPLLPQQF FYPSVCLDLCWAMPGTWK in isoform 2. | VSP_011003 | |||||
| Natural variant | 90 | 1 | G → A. Corresponds to variant rs3803763 [ dbSNP | Ensembl ]. | VAR_051300 | |||||
| Natural variant | 165 | 1 | P → T. Corresponds to variant rs11649804 [ dbSNP | Ensembl ]. | VAR_024344 | |||||
| Natural variant | 939 | 1 | Q → P. Corresponds to variant rs1759075 [ dbSNP | Ensembl ]. | VAR_051301 | |||||
Experimental info | |||||||||
| Sequence conflict | 440 | 1 | S → L in AAO31738. Ref.2 | ||||||
| Sequence conflict | 1302 | 1 | L → F in AAO31738. Ref.2 | ||||||
| Sequence conflict | 1513 | 1 | G → A in AAO31738. Ref.2 | ||||||
| Sequence conflict | 1682 | 1 | T → A in CAD39144. Ref.5 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "RAI1 is a novel polyglutamine encoding gene that is deleted in Smith-Magenis syndrome patients." Seranski P., Hoff C., Radelof U., Henning S., Reinhard R., Schwartz C.E., Heiss N., Poustka A. Gene 270:69-76(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), POLYMORPHISM OF POLY-GLN REGION, INVOLVEMENT IN SMITH-MAGENIS SYNDROME. |
| [2] | "Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia." Toulouse A., Rochefort D., Roussel J., Joober R., Rouleau G.A. Genomics 82:162-171(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY. |
| [3] | "Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O. DNA Res. 8:85-95(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Brain. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). Tissue: Muscle. |
| [5] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 622-1906. Tissue: Melanoma and Testis. |
| [6] | "Mutations in RAI1 associated with Smith-Magenis syndrome." Slager R.E., Newton T.L., Vlangos C.N., Finucane B., Elsea S.H. Nat. Genet. 33:466-468(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN SMITH-MAGENIS SYNDROME. |
| [7] | "CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2)." Hayes S., Turecki G., Brisebois K., Lopes-Cendes I., Gaspar C., Riess O., Ranum L.P., Pulst S.M., Rouleau G.A. Hum. Mol. Genet. 9:1753-1758(2000) [PubMed] [Europe PMC] [Abstract] Cited for: ROLE OF THE POLY-GLN REGION IN SPINOCEREBELLAR ATAXIA TYPE 2. |
| [8] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [9] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-683; THR-696; SER-880; SER-892; SER-1122; SER-1352; SER-1358; SER-1374 AND SER-1431, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-683; SER-1064; THR-1068 AND SER-1374, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [11] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568; SER-683; SER-1352; SER-1358 AND SER-1374, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AJ271790 mRNA. Translation: CAC20423.1. AJ271791 Genomic DNA. Translation: CAC20424.1. AY172136 mRNA. Translation: AAO31738.1. AB058723 mRNA. Translation: BAB47449.1. Different initiation. BC021209 mRNA. Translation: AAH21209.1. AL133649 mRNA. Translation: CAB63768.1. AL834468 mRNA. Translation: CAD39127.1. AL834486 mRNA. Translation: CAD39144.1. |
| IPI | IPI00449923. IPI00449924. IPI00449925. IPI00449926. |
| PIR | T43490. |
| RefSeq | NP_109590.3. NM_030665.3. |
| UniGene | Hs.655395. Hs.727059. |
3D structure databases | |
| ProteinModelPortal | Q7Z5J4. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q7Z5J4. 3 interactions. |
| MINT | MINT-1477867. |
| STRING | 9606.ENSP00000323074. |
PTM databases | |
| PhosphoSite | Q7Z5J4. |
Polymorphism databases | |
| DMDM | 50400978. |
Proteomic databases | |
| PaxDb | Q7Z5J4. |
| PRIDE | Q7Z5J4. |
Protocols and materials databases | |
| DNASU | 10743. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000353383; ENSP00000323074; ENSG00000108557. |
| GeneID | 10743. |
| KEGG | hsa:10743. |
| UCSC | uc002grm.3. human. |
Organism-specific databases | |
| CTD | 10743. |
| GeneCards | GC17P017525. |
| H-InvDB | HIX0013588. |
| HGNC | HGNC:9834. RAI1. |
| HPA | HPA023898. |
| MIM | 182290. phenotype. 607642. gene. |
| neXtProt | NX_Q7Z5J4. |
| Orphanet | 1713. 17p11.2 microduplication syndrome. 819. Smith-Magenis syndrome. |
| PharmGKB | PA34188. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG146768. |
| HOVERGEN | HBG056862. |
| OrthoDB | EOG4CZBF0. |
| PhylomeDB | Q7Z5J4. |
Gene expression databases | |
| ArrayExpress | Q7Z5J4. |
| Bgee | Q7Z5J4. |
| CleanEx | HS_RAI1. |
| Genevestigator | Q7Z5J4. |
| GermOnline | ENSG00000108557. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR001965. Znf_PHD. [Graphical view] |
| SMART | SM00249. PHD. 1 hit. [Graphical view] |
| PROSITE | PS01359. ZF_PHD_1. False negative. PS50016. ZF_PHD_2. False negative. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | RAI1. human. |
| GenomeRNAi | 10743. |
| NextBio | 40793. |
| SOURCE | Search... |
Entry information
| Entry name | RAI1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q7Z5J4 Secondary accession number(s): Q8N3B4 Q9UF69 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
